Hiroshi Nishioka
Overview
Explore the profile of Hiroshi Nishioka including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
148
Citations
1349
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Mukoyama Y, Moriguchi S, Takizawa F, Ogawa A, Ogawa T, Ito J, et al.
Clin Endocrinol (Oxf)
. 2025 Feb;
PMID: 40018845
Objective: Craniopharyngioma (CP) has mostly nonspecific symptoms, leading to delayed diagnosis. Early indicators of CP in children are needed for early diagnosis and to detect postoperative growth patterns for their...
2.
Nishiyama M, Fukuhara N, Nishioka H, Yamada S
Cancers (Basel)
. 2025 Feb;
17(4).
PMID: 40002269
Double pituitary neuroendocrine tumors (double PitNETs) are two distinct tumors in the same gland and are infrequent in clinical practice. In typical double PitNETs, an MRI detects two separate tumors...
3.
Wada M, Kamata H, Shima N, Nitta A, Kakehashi H, Fujii S, et al.
Forensic Toxicol
. 2024 Dec;
PMID: 39695054
Purpose: Suvorexant is an orexin receptor antagonist used in the treatment of insomnia. In this study, we investigated the urinary excretion profiles of suvorexant and its major metabolites, including conjugates,...
4.
Tadokoro N, Kainuma S, Tonai K, Koyamoto T, Kawamoto N, Kakuta T, et al.
Artif Organs
. 2024 Nov;
49(3):469-476.
PMID: 39564969
Background: Peripheral veno-arterial extracorporeal membrane oxygenation (ECMO) is a powerful life-saving tool; however, it can sometimes induce severe pulmonary edema in patients with critical heart failure. We report favorable outcomes...
5.
Matsuda T, Kono T, Taki Y, Sakuma I, Fujimoto M, Hashimoto N, et al.
iScience
. 2024 Nov;
27(11):111068.
PMID: 39483146
Craniopharyngiomas, including adamantinomatous (ACP) and squamous papillary (PCP) types, are challenging to treat because of their proximity to crucial pituitary structures. This study aimed to characterize the cellular composition, tumor...
6.
Nishioka H, Takashimizu I, Yuzuriha S
J Plast Reconstr Aesthet Surg
. 2024 Oct;
99:248-255.
PMID: 39388768
Background: Lymphatic vessels support wound recovery and absorb excess fluid. Blepharoplasty involves excess tissue excision, and this study investigated the relationship between lymph vessel density in excised tissue and the...
7.
Nitta A, Shima N, Kamata H, Wada M, Matsumoto K, Kakehashi H, et al.
Forensic Toxicol
. 2024 Aug;
43(1):97-107.
PMID: 39122974
Purpose: This study examined the applicability of hair analysis as an approach to identify suvorexant (SUV) and lemborexant (LEM) intake by analyzing black hair specimens collected from study participants after...
8.
Taniguchi H, Nishioka H, Kuriyama E, Inoue Y, Okumoto T
Plast Reconstr Surg Glob Open
. 2024 May;
12(5):e5828.
PMID: 38798927
Superior orbital fissure syndrome (SOFS) is a rare complication of craniofacial fracture, caused by damage to cranial nerves Ⅲ, Ⅳ, Ⅴ, and Ⅵ, which typically is associated with ophthalmoplegia, blepharoptosis,...
9.
Nishioka H
No Shinkei Geka
. 2024 May;
52(3):631-645.
PMID: 38783506
In the World Health Organization 2022 classification, a nomenclature change from pituitary adenoma to pituitary neuroendocrine tumor(PitNET)was introduced to indicate rare but potentially malignant behavior. No grading system is available...
10.
Fukuhara N, Nishihara T, Sato K, Inoshita N, Tatsushima K, Yamaguchi-Okada M, et al.
Acta Neurochir (Wien)
. 2024 May;
166(1):218.
PMID: 38750340
Purpose: The aim of this study was to evaluate the treatment outcomes of neuroendoscopic cyst partial resection (ECPR) combined with stereotactic radiotherapy (SRT) for cystic craniopharyngiomas. Methods: In this retrospective...